Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jaime Flerlage"'
Autor:
Hema Dave, Faye Willen, Audrey Mauguen, Jaime Flerlage, Martha Pacheco, Ilia N. Buhtoiarov, Jaclyn Rosenzweig, Robin E. Norris, Branko Cuglievan, Rebecca J. Deyell, Lianna J. Marks, Anna Franklin, Adam Paul Yan, Paul Harker-Murray, Lisa Giulino Roth, Christopher J. Forlenza, Kasey J. Leger, Jennifer Krajewski
Publikováno v:
Blood. 138:2465-2465
Background: Although the prognosis for children with Hodgkin lymphoma (HL) is excellent, up to 25% of patients experience relapse and require salvage therapy. Event-free survival (EFS) for patients with relapsed or refractory disease (R/R) who requir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e94bc43be3dea8039f7fc312fbff02a2
https://doi.org/10.1182/blood-2021-151808
https://doi.org/10.1182/blood-2021-151808
Autor:
Jaime Flerlage, Jesse Turner, I-Chan Huang, John T. Lucas, Leslie L. Robison, Melissa M. Hudson, Nickhill Bhakta, Kalatu Davies, Yichen Chen, Monika L. Metzger, F. Lennie Wong
Publikováno v:
Blood. 134:267-267
Background: Children and young adults diagnosed with HR-HL have a 5-year survival rate of >95%. Yet, as compared to the general population, survivors remain at elevated risk for therapy-related early mortality and excess long-term morbidity. Second m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70d802d9ffc935e57721c64f5a8d2df7
https://doi.org/10.1182/blood-2019-124907
https://doi.org/10.1182/blood-2019-124907